Publication: Bullous pemphigoid treated with intravenous immunoglobulin
1
Issued Date
2014-01-01
Resource Type
ISSN
00114162
Other identifier(s)
2-s2.0-84900521240
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cutis. Vol.93, No.5 (2014), 264-268
Suggested Citation
Papapit Tuchinda, Simon Ritchie, Anthony A. Gaspari Bullous pemphigoid treated with intravenous immunoglobulin. Cutis. Vol.93, No.5 (2014), 264-268. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/34633
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Bullous pemphigoid treated with intravenous immunoglobulin
Author(s)
Other Contributor(s)
Abstract
Bullous pemphigoid (BP) is a blistering autoimmune disease that primarily affects elderly patients who commonly present with comorbidities. Side effects from long-term treatment with conventional cytotoxic and immunosuppressive agents may increase morbidity and mortality in this patient population. We present a case of BP in a 78-year-old woman with an active pulmonary Mycobacterium avium-intracellulare complex (MAC) infection that precluded the use of systemic corticosteroids or other immunosuppressants. Our patient was successfully treated with intravenous immunoglobulin (IVIG) monotherapy, which may provide an alternative treatment option for BP patients who are unable to tolerate cytotoxic or immunosuppressive therapies. © Cutis 2014.